Research - Sunnyvale, California, United States
Molecular Decisions (MDI) is an oncology diagnostic company focused on developing proteomics-based assays that provide physicians with real-time information to direct their clinical decision-making and provide the best-personalized care. Our unique proteomic platform measures modifications occurring to protein targets of therapeutic agents which can predict therapeutic drug efficacy and positive patient outcomes.
DoubleClick
Gmail
Varnish
Mobile Friendly
Google Cloud Hosting